Sonoma Pharmaceuticals Statistics
Total Valuation
SNOA has a market cap or net worth of $3.87 million. The enterprise value is -$1.25 million.
Important Dates
The last earnings date was Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SNOA has 1.62 million shares outstanding. The number of shares has increased by 225.07% in one year.
| Current Share Class | 1.62M |
| Shares Outstanding | 1.62M |
| Shares Change (YoY) | +225.07% |
| Shares Change (QoQ) | +41.59% |
| Owned by Insiders (%) | 1.30% |
| Owned by Institutions (%) | 1.51% |
| Float | 1.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| Forward PS | 0.21 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | 30.00 |
| P/OCF Ratio | 24.34 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.34 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.92 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.83% and return on invested capital (ROIC) is -46.24%.
| Return on Equity (ROE) | -64.83% |
| Return on Assets (ROA) | -19.72% |
| Return on Invested Capital (ROIC) | -46.24% |
| Return on Capital Employed (ROCE) | -44.79% |
| Revenue Per Employee | $1.40M |
| Profits Per Employee | -$374,800 |
| Employee Count | 10 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 2.93 |
Taxes
In the past 12 months, SNOA has paid $10,000 in taxes.
| Income Tax | 10,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.21% in the last 52 weeks. The beta is 1.43, so SNOA's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | -24.21% |
| 50-Day Moving Average | 2.65 |
| 200-Day Moving Average | 3.70 |
| Relative Strength Index (RSI) | 36.13 |
| Average Volume (20 Days) | 52,942 |
Short Selling Information
The latest short interest is 41,494, so 2.57% of the outstanding shares have been sold short.
| Short Interest | 41,494 |
| Short Previous Month | 23,715 |
| Short % of Shares Out | 2.57% |
| Short % of Float | 2.60% |
| Short Ratio (days to cover) | 0.68 |
Income Statement
In the last 12 months, SNOA had revenue of $13.97 million and -$3.75 million in losses. Loss per share was -$3.64.
| Revenue | 13.97M |
| Gross Profit | 5.03M |
| Operating Income | -4.46M |
| Pretax Income | -4.58M |
| Net Income | -3.75M |
| EBITDA | -4.32M |
| EBIT | -4.46M |
| Loss Per Share | -$3.64 |
Full Income StatementBalance Sheet
The company has $5.24 million in cash and $119,000 in debt, giving a net cash position of $5.12 million or $3.17 per share.
| Cash & Cash Equivalents | 5.24M |
| Total Debt | 119,000 |
| Net Cash | 5.12M |
| Net Cash Per Share | $3.17 |
| Equity (Book Value) | 4.87M |
| Book Value Per Share | 3.01 |
| Working Capital | 8.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $159,000 and capital expenditures -$30,000, giving a free cash flow of $129,000.
| Operating Cash Flow | 159,000 |
| Capital Expenditures | -30,000 |
| Free Cash Flow | 129,000 |
| FCF Per Share | $0.08 |
Full Cash Flow StatementMargins
Gross margin is 35.98%, with operating and profit margins of -31.94% and -26.82%.
| Gross Margin | 35.98% |
| Operating Margin | -31.94% |
| Pretax Margin | -26.75% |
| Profit Margin | -26.82% |
| EBITDA Margin | -30.88% |
| EBIT Margin | -31.94% |
| FCF Margin | 0.92% |